Delivery Order SPE2DB22D2211-SPE2DB25FSCCT
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency to supply Ondansetron HCl 8 mg tablets (30-count packages) with a contract value of $15,908.50. This is a firm fixed-price, non-set-aside award with an ultimate completion date of September 12, 2025, and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $27,766.85 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Ondansetron HCL 8 mg tablets in quantities of 30 tablets, with a ceiling value of $20,173.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and is scheduled for completion by August 8, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,506.30 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 30 units. This contract, awarded on August 12, 2025, with completion scheduled for August 13, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 30, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Ondansetron ODT 8 mg tablets in a 30-count quantity. This is a non-set-aside, competitively awarded firm fixed price delivery order with a ceiling value of $1,438.73 and an ultimate completion date of July 31, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,931.21 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ondansetron HCL 8 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for Ondansetron HCL 8 mg tablets (30-count) with a ceiling value of $1,522.56. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,487.53 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 21, 2025, with completion targeted for August 22, 2025. This firm fixed-price, non-set-aside delivery order is being performed in Conshohocken, Pennsylvania, the vendor's corporate headquarters location. The award represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio to federal customers. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ondansetron HCl 8 mg tablets (30-count units) with a ceiling value of $7,423.50. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. The award represents a single delivery order drawn...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count supply) with a ceiling value of $2,320.65. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCCTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ondansetron HCl 8 mg tablets in quantities of 30 units, with a ceiling value of $2,327.64. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical products and medical supplies, from brand-name and generic medications to specialized healthcare commodities across multiple therapeutic domains. As a primary vendor under the DLA Troop Support Medical umbrella contract, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting history demonstrates consistent competitive performance across delivery orders with firm fixed pricing, positioning it as a key supplier for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/4/25 |